Genetic Factors in Itching: FLG, Histamine Genes and Pruritus

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on skin & genetics. Browse all Skin & Genetics education

Itch — clinically called pruritus — is one of the most common sensations, and for millions of people it becomes chronic and disruptive. While dry skin, allergies, and irritants are familiar triggers, genetics help explain why some people itch more easily, develop eczema, or react strongly to histamine. Understanding the inherited factors can make sense of patterns that lifestyle changes alone do not.

How itch signaling works

Itch begins at specialized nerve endings in the skin called pruriceptors. They respond to mediators such as histamine, certain proteases, and the cytokine interleukin-31, then relay signals through the spinal cord to the brain. Some itch is histamine-driven (and responds to antihistamines); much chronic itch is non-histaminergic, travelling different molecular routes. Genetic variation along any of these steps can raise or lower how readily the itch signal fires.

FLG and the skin barrier

The FLG gene encodes filaggrin, a protein essential for a strong, water-retaining skin barrier. Loss-of-function variants in FLG are among the best-established genetic risk factors for atopic dermatitis (eczema) and ichthyosis vulgaris, both marked by dryness and intense itch. When the barrier is weak, moisture escapes and irritants and allergens penetrate more easily, priming the skin to itch. FLG status is a clear example of genetics shaping a real, testable pathway.

Histamine metabolism: HNMT and DAO

How efficiently your body clears histamine influences itch and allergic-type reactions. The HNMT gene (histamine N-methyltransferase) breaks down histamine inside cells, while the AOC1 gene encodes diamine oxidase (DAO), which degrades histamine in the gut. Reduced-activity variants in these genes have been studied in connection with histamine sensitivity. People who clear histamine slowly may notice more flushing, hives, or itch after histamine-rich foods or exposures.

Inflammatory itch and IL-31

Interleukin-31 (IL31) is a cytokine released by immune cells that acts directly on itch nerves. It has become a major focus in chronic itch research, and drugs targeting its pathway are being developed for conditions like atopic dermatitis and prurigo nodularis. Variation in IL31 and its receptor genes contributes to why inflammatory itch is more severe in some people — a reminder that itch is as much an immune signal as a skin one. This immune dimension also explains why moisturizers alone are not enough for everyone: when the itch is driven by cytokine signaling rather than dryness, calming the immune response is often what finally brings relief, and the balance between the two differs from person to person.

When to talk to a provider

Persistent or widespread itch without an obvious rash can sometimes reflect systemic causes — thyroid, liver, kidney, or other conditions — and deserves medical evaluation. Genetics can explain a tendency toward barrier weakness or histamine sensitivity, but it does not replace a diagnosis. Evidence-based care, from targeted moisturizers and trigger avoidance to prescription therapies, is set by a qualified clinician based on your full picture.

What genetic pathway context can add

The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including inflammation- and barrier-related pathways tied to genes such as FLG and HNMT. It offers pathway-level context about your biology — not a diagnosis and not a treatment plan for any skin condition. Used alongside a provider’s assessment, it can help you understand the tendencies behind your symptoms.

Frequently Asked Questions

Can itching really be genetic?

Yes. Inherited variation shapes the skin barrier and immune signaling behind itch. Loss-of-function FLG variants strongly raise the risk of eczema-related itch, and genes affecting histamine metabolism influence sensitivity. Genetics sets a tendency; triggers like dryness, allergens, and stress determine when itch actually flares.

What is the FLG gene’s role in itchy skin?

FLG encodes filaggrin, which builds a strong moisture-retaining skin barrier. When loss-of-function variants weaken that barrier, skin loses water and lets irritants in, driving dryness and intense itch. FLG variants are among the most established genetic risk factors for atopic dermatitis and ichthyosis vulgaris.

Does histamine intolerance cause itching?

It can. Genes such as HNMT and AOC1 (DAO) control how fast the body clears histamine. Reduced-activity variants may leave more histamine circulating, contributing to flushing, hives, and itch after histamine-rich foods or exposures. A provider can help confirm whether histamine sensitivity is involved.

Curious how your own biology maps to these pathways? The Precision Peptide Genetic Test gives you pathway-level genetic context to bring into an informed conversation with your healthcare provider — test before you invest.

Disclaimer: The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not diagnose, treat, cure, or prevent any condition, and it does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol or making changes to your care.

This article is part of the PlexusDx Education Hub. Browse all Skin & Genetics education